NCT03984500View on ClinicalTrials.gov

A Program to Increase Sickle Cell Trait Knowledge Among Parent of Young Children Identified in Newborn Screening

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
Sickle Cell Trait
Interventions
OTHER

Education

SCTaware education (Phase II) will be compared to Ohio's current in-person SCT education (Phase I).

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Susan Creary

OTHER

NCT03984500 - A Program to Increase Sickle Cell Trait Knowledge Among Parent of Young Children Identified in Newborn Screening | Biotech Hunter | Biotech Hunter